Psi Advisors, LLC Abb Vie Inc. Transaction History

Psi Advisors, LLC

$338 Million
Q3 2024

A detailed history of Psi Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Psi Advisors, LLC holds 3,834 shares of ABBV stock, worth $690,120. This represents 0.22% of its overall portfolio holdings.

Number of Shares

3,834

Previous 3,903 1.77%

Holding current value

$690,120

Previous $669,000 13.15%

% of portfolio

0.22%

Previous 0.21%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$163.84 - $199.33 $11,304 - $13,753	-69 Reduced 1.77%	3,834 $757,000
Q2 2024 Jul 23, 2024	BUY	$154.79 - $180.76 $11,918 - $13,918	77 Added 2.01%	3,903 $669,000
Q1 2024 Apr 24, 2024	SELL	$159.82 - $182.1 $104,682 - $119,275	-655 Reduced 14.62%	3,826 $696,000
Q4 2023 Feb 01, 2024	BUY	$137.6 - $154.97 $9,769 - $11,002	71 Added 1.61%	4,481 $694,000
Q3 2023 Oct 13, 2023	BUY	$133.59 - $154.65 $30,859 - $35,724	231 Added 5.53%	4,410 $657,000
Q2 2023 Jul 21, 2023	SELL	$132.51 - $164.9 $56,581 - $70,412	-427 Reduced 9.27%	4,179 $563,000
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $27,909 - $32,142	193 Added 4.37%	4,606 $734,000
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $1.79 Million - $2.15 Million	-12,963 Reduced 74.6%	4,413 $0
Q3 2022 Oct 20, 2022	SELL	$134.21 - $153.93 $840,691 - $964,217	-6,264 Reduced 26.5%	17,376 $2.33 Million
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $370,748 - $471,342	-2,694 Reduced 10.23%	23,640 $3.62 Million
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $47,908 - $59,441	-363 Reduced 1.36%	26,334 $4.27 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $74,771 - $94,607	696 Added 2.68%	26,697 $3.62 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $227,696 - $258,469	2,140 Added 8.97%	26,001 $2.81 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $117,519 - $130,923	1,117 Added 4.91%	23,861 $2.69 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $1.6 Million - $1.76 Million	15,621 Added 219.3%	22,744 $2.46 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $332,665 - $449,133	4,133 Added 138.23%	7,123 $763,000
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $256,870 - $301,481	2,990 New	2,990 $261,000
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $35,991 - $54,566	-558 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $40,248 - $50,359	558 New	558 $49,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Psi Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Psi Advisors, LLC with notifications on news.

Account